Mitochondrial mutations drive prostate cancer aggression.
Mitochondrial mutations drive prostate cancer aggression.
复制标题
DOI:
10.1038/s41467-017-00377-y
复制
发表时间:
2017-09-22
影响因子:
16.6
通讯作者:
Boutros PC
中科院分区:
文献类型:
--
作者:
Hopkins JF;Sabelnykova VY;Weischenfeldt J;Simon R;Aguiar JA;Alkallas R;Heisler LE;Zhang J;Watson JD;Chua MLK;Fraser M;Favero F;Lawerenz C;Plass C;Sauter G;McPherson JD;van der Kwast T;Korbel J;Schlomm T;Bristow RG;Boutros PC
Nuclear mutations are well known to drive tumor incidence, aggression and response to therapy. By contrast, the frequency and roles of mutations in the maternally inherited mitochondrial genome are poorly understood. Here we sequence the mitochondrial genomes of 384 localized prostate cancer patients, and identify a median of one mitochondrial single-nucleotide variant (mtSNV) per patient. Some of these mtSNVs occur in recurrent mutational hotspots and associate with aggressive disease. Younger patients have fewer mtSNVs than those who diagnosed at an older age. We demonstrate strong links between mitochondrial and nuclear mutational profiles, with co-occurrence between specific mutations. For example, certain control region mtSNVs co-occur with gain of the MYC oncogene, and these mutations are jointly associated with patient survival. These data demonstrate frequent mitochondrial mutation in prostate cancer, and suggest interplay between nuclear and mitochondrial mutational profiles in prostate cancer. In prostate cancer, the role of mutations in the maternally-inherited mitochondrial genome are not well known. Here, the authors demonstrate frequent, age-dependent mitochondrial mutation in prostate cancer. Strong links between mitochondrial and nuclear mutational profiles are associated with clinical aggressivity.
登录
查看更多内容
影响因子:
4.5
作者:
Ding J;Sidore C;Butler TJ;Wing MK;Qian Y;Meirelles O;Busonero F;Tsoi LC;Maschio A;Angius A;Kang HM;Nagaraja R;Cucca F;Abecasis GR;Schlessinger D
通讯作者:
Schlessinger D
影响因子:
7.7
作者:
Ju YS;Alexandrov LB;Gerstung M;Martincorena I;Nik-Zainal S;Ramakrishna M;Davies HR;Papaemmanuil E;Gundem G;Shlien A;Bolli N;Behjati S;Tarpey PS;Nangalia J;Massie CE;Butler AP;Teague JW;Vassiliou GS;Green AR;Du MQ;Unnikrishnan A;Pimanda JE;Teh BT;Munshi N;Greaves M;Vyas P;El-Naggar AK;Santarius T;Collins VP;Grundy R;Taylor JA;Hayes DN;Malkin D;ICGC Breast Cancer Group;ICGC Chronic Myeloid Disorders Group;ICGC Prostate Cancer Group;Foster CS;Warren AY;Whitaker HC;Brewer D;Eeles R;Cooper C;Neal D;Visakorpi T;Isaacs WB;Bova GS;Flanagan AM;Futreal PA;Lynch AG;Chinnery PF;McDermott U;Stratton MR;Campbell PJ
通讯作者:
Campbell PJ
影响因子:
64.5
作者:
Cancer Genome Atlas Research Network
通讯作者:
Cancer Genome Atlas Research Network
影响因子:
14.9
作者:
CORTOPASSI, GA;ARNHEIM, N
通讯作者:
ARNHEIM, N
影响因子:
9.8
作者:
Kloss-Brandstaetter, Anita;Schaefer, Georg;Kronenberg, Florian
通讯作者:
Kronenberg, Florian